EP1906926
Lyfjafræðileg samsetning sem inniheldur 2,3-díhýdró-6-nítróimídasó[2,1-b]oxasól afleiður.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.7.2006EP published:
1.12.2010EP application number:
06781620.7
EP translation filed:
28.12.2010Grant published:
15.1.2011EPO information:
European Patent Register
Max expiry date:
18.7.2026Expiry date:
18.7.2026
Title:
PHARMACEUTICAL COMPOSITION COMPRISING 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLE DERIVATIVES
Timeline
Owner
Name:
OTSUKA PHARMACEUTICAL CO., LTD.Address:
9, Kanda Tsukasamachi 2-chome, 101-8535, Chiyoda-kuTokyo, JP
Inventor
Name:
KAWASAKI, JunichiOTSUKA PHARMACEUTICAL CO., LTD.Address:
Tokushima-shi, Tokushima;, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2005218563Date:
28.7.2005Country:
JP
Classification
Categories:
A61K 9/14, A61K 31/454, A61K 31/496, A61K 31/47
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.7.2011
Expires: 18.7.2012
Payer: Árnason Faktor
Number: 7
Paid: 8.6.2012
Expires: 18.7.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 6.6.2013
Expires: 18.7.2014
Payer: Árnason Faktor
Number: 9
Paid: 10.6.2014
Expires: 18.7.2015
Payer: Árnason Faktor
Number: 10
Paid: 9.6.2015
Expires: 18.7.2016
Payer: Árnason Faktor
Number: 11
Paid: 8.6.2016
Expires: 18.7.2017
Payer: Árnason Faktor
Number: 12
Paid: 7.6.2017
Expires: 18.7.2018
Payer: Árnason Faktor
Number: 13
Paid: 7.6.2018
Expires: 18.7.2019
Payer: Árnason Faktor
Number: 14
Paid: 5.6.2019
Expires: 18.7.2020
Payer: Árnason Faktor
Number: 15
Paid: 12.6.2020
Expires: 18.7.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.6.2021
Expires: 18.7.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.6.2022
Expires: 18.7.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 11.6.2023
Expires: 18.7.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 7.6.2024
Expires: 18.7.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 8.7.2025
Expires: 18.7.2026
Payer: Árnason Faktor ehf.